{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:41:53Z","timestamp":1762864913480},"reference-count":11,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p>RATIONALE: Metabolic acidosis induced by topiramate is a well documented but infrequent adverse event. The objective was to demonstrate the lowering of carbon dioxide serum levels, which is usually asymptomatic but may facilitate the occurrence of metabolic acidosis in patients using topiramate. METHODS: We evaluated, prospectively, the carbon dioxide serum levels of 18 patients seen at the epilepsy clinic of our university hospital, before and 3 months after introducing topiramate. RESULTS: Five patients were female and 13 were male, age ranging from 2 to 16 years old (mean=9.3). Carbon dioxide mean serum levels were 25 and 21.2 mmol\/L (normal = 22 to 30), before and 3 months after introducing topiramate, respectively. Dose ranged from 2.08 to 11.76 mg\/kg\/day (mean=6.7mg\/kg\/day). Adverse events were anorexia, nausea and somnolence. CONCLUSION: We conclude that the lowering of carbon dioxide serum levels induced by topiramate is mostly asymptomatic, but may facilitate the occurrence of metabolic acidosis. Since patients in use of topiramate have refractory epilepsy, they may need epilepsy surgery, and must be carefully monitored for the risk of metabolic acidosis during surgery.<\/jats:p>","DOI":"10.1590\/s0004-282x2000000600007","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:27:54Z","timestamp":1113575274000},"page":"1021-1024","source":"Crossref","is-referenced-by-count":12,"title":["Predisposition to metabolic acidosis induced by topiramate"],"prefix":"10.1590","volume":"58","author":[{"given":"MARIA AUGUSTA","family":"MONTENEGRO","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARILISA M.","family":"GUERREIRO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNA ELISA","family":"SCOTONI","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARLOS A.M.","family":"GUERREIRO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"The treatment of epilepsy","first-page":"471","volume-title":"Topiramate","author":"Reife RA","year":"1996"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1528-1157.1999.tb00781.x","article-title":"Topiramate and metabolic acidosis","volume":"40","author":"Wilner A","year":"1999","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1592\/phco.20.1.105.34662","article-title":"Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy","volume":"20","author":"Stowe CD","year":"2000","journal-title":"Pharmacotherapy","ISSN":"http:\/\/id.crossref.org\/issn\/0277-0008","issn-type":"print"},{"key":"ref4","first-page":"Suppl 7","article-title":"Topiramate and metabolic acidosis in pediatric epilepsy","volume":"40","author":"Takeoka M","year":"1999","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01997718","article-title":"Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective study","volume":"17","author":"Tartara A","year":"1996","journal-title":"Ital J Neurol Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0392-0461","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/019262339202000111","article-title":"Rat urinary bladder hyperplasia induced by oral administration of carbonic nhydrase inhibitors","volume":"20","author":"Molon-Noblot S","year":"1992","journal-title":"Toxicol Pathol","ISSN":"http:\/\/id.crossref.org\/issn\/0192-6233","issn-type":"print"},{"key":"ref7","first-page":"S153","article-title":"Investigation of the mechanistic basis of topiramate-associated nephrolitiasis: examination of urinary and serum constituents","volume":"36","author":"Wasserstein AG","year":"1995","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1528-1157.1996.tb06029.x","article-title":"Safety of topiramate: adverse events and relationship to dosing","volume":"37","author":"Shorvon SD","year":"1996","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1071-9091(97)80007-1","article-title":"Topiramate","volume":"4","author":"Glauser TA","year":"1997","journal-title":"Sem Ped Neurol"},{"key":"ref10","first-page":"S153","article-title":"Nephrolitiasis during treatment with topiramate","volume":"36","author":"Wasserstein AG","year":"1995","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/S0004-282X1999000200001","article-title":"A pilot study of topiramate in children with Lennox-Gastaut syndrome","volume":"57","author":"Guerreiro MM","year":"1998","journal-title":"Arq Neuropsiquiat"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v58n4\/3396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T20:05:02Z","timestamp":1495656302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2000000600007&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0004-282X2000000600007"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2000000600007","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}